Search research articles
Contact Us
Filters
Showing results (241-250 of 256) with videos related to
Page
of 26
Sort By:
Genomics
|
July 8, 1998
Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase
C M Li, S B Hong, G Kopal, et al.
Journal of Inherited Metabolic Disease
|
May 7, 2005
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study
H Pavlů-Pereira, B Asfaw, H Poupctová, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 1997
Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment
Y Liu, A Hoffmann, A Grinberg, et al.
The Journal of Biological Chemistry
|
December 20, 1996
Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease
J Koch, S Gärtner, C M Li, et al.
Biochimica Et Biophysica Acta
|
April 21, 1999
The human homolog of Drosophila cornichon protein is differentially expressed in alloactivated T-cells
N Utku, G C Bulwin, S Beinke, et al.
Biochimica Et Biophysica Acta
|
July 26, 1985
The effect of detergents on immunoprecipitability of lysosomal sphingomyelinase
M Driessen, G Weitz, E M Brouwer-Kelder, et al.
Nature Genetics
|
October 1, 1995
Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism
K Sango, S Yamanaka, A Hoffmann, et al.
Bioscience Reports
|
December 1, 1984
Immunological studies on lysosomal sphingomyelinase: identification of a 28 000-Da component deficient in urine from patients with Niemann-Pick disease types A and B
A W Schram, M Dreissen, J Bastiaannet, et al.
Neurochemical Research
|
October 11, 2002
Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model
S Martino, C Cavalieri, C Emiliani, et al.
Neurology
|
February 5, 1999
GM2 gangliosidosis AB variant: clinical and biochemical studies of a Japanese patient
H Sakuraba, K Itoh, M Shimmoto, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 256) with videos related to
Sort By:
Page
of 26
Genomics
|
July 8, 1998
Cloning and characterization of the full-length cDNA and genomic sequences encoding murine acid ceramidase
C M Li, S B Hong, G Kopal, et al.
Journal of Inherited Metabolic Disease
|
May 7, 2005
Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study
H Pavlů-Pereira, B Asfaw, H Poupctová, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 1997
Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment
Y Liu, A Hoffmann, A Grinberg, et al.
The Journal of Biological Chemistry
|
December 20, 1996
Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase. Identification Of the first molecular lesion causing Farber disease
J Koch, S Gärtner, C M Li, et al.
Biochimica Et Biophysica Acta
|
April 21, 1999
The human homolog of Drosophila cornichon protein is differentially expressed in alloactivated T-cells
N Utku, G C Bulwin, S Beinke, et al.
Biochimica Et Biophysica Acta
|
July 26, 1985
The effect of detergents on immunoprecipitability of lysosomal sphingomyelinase
M Driessen, G Weitz, E M Brouwer-Kelder, et al.
Nature Genetics
|
October 1, 1995
Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism
K Sango, S Yamanaka, A Hoffmann, et al.
Bioscience Reports
|
December 1, 1984
Immunological studies on lysosomal sphingomyelinase: identification of a 28 000-Da component deficient in urine from patients with Niemann-Pick disease types A and B
A W Schram, M Dreissen, J Bastiaannet, et al.
Neurochemical Research
|
October 11, 2002
Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model
S Martino, C Cavalieri, C Emiliani, et al.
Neurology
|
February 5, 1999
GM2 gangliosidosis AB variant: clinical and biochemical studies of a Japanese patient
H Sakuraba, K Itoh, M Shimmoto, et al.
Page
of 26